Novo Nordisk said on Wednesday that she would start selling her drug for Wegovy weight loss at a discount price of $ 499 a month for paying money, as she accumulates in the competitive dynamics of the US overweight drug market.
Now it sells vials from everyone, but two doses with higher strength of the medicine through Lillydirect. The lowest dose costs $ 349 a month and others cost $ 499 a month.
Novo said that his deducted Wegovy would be available in pens of all hard dosage points for unsecured patients or patients acceptable with trade insurance who have no coverage of overweight medication through his Novocare pharmacy program.
The shares listed by Novo’s SH.BA increased 4.2% to $ 91.16 in the morning trading.
The drug ingredients led by the Industry Trade Group, the Association of Outsourcing Transfer Facilities FDA last month for its decision to remove Wegovy from its list of drugs in absentia.
Company shares almost tripled last year, giving it a $ 9 billion market capitalization.
#Novo #Nordisk #sell #Wegovy #month #paying #customers
Image Source : nypost.com